Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications drug utilization physician survey intron ® europe
Causal Inference for Regulatory-Grade RWE Among the hurdles for making your healthcare interventions available to patients is being able to meet regulatory requirements for estimating the product's safety and/or effectiveness using real-world data (RWD). …
… AANP National Conference. Nurse practitioners' and physician assistants' communication with patients/parents on …
… the first season of vaccine availability: results from a survey of recently vaccinated older adults in the United … settings in the United States: patient experiences from a survey of recently vaccinated adults. La E, Sweeney C, …
… Therapeutic Experience Explore our Projects, Publications, and Researchers by Therapeutic Area To help … context. We've conducted over 6,600 projects-- spanning drug development, commercialization, and safety --across all …
Real-World Evidence Fills Gaps in Blood Cancer Research Share on: February 12, 2022 Most of what we know about treatments, adverse events, and the overall survival of patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) comes …
… and beyond What do the joint clinical assessments (JCA) in Europe mean for your pharma or medtech company? The parallel …
… Research Analyst for the Mississippi Evidence-based Drug Utilization Review (MS-DUR) Initiative at the University of …
… create reports for regulatory and HTA purposes as well as publications, interactive tools, and models to help you …
… Sentinel Initiative, launched in 2007 by the US Food and Drug Administration (FDA), is a national electronic data …
… 2024 Contributed by: Anne Heyes, MBA VP, Value and Access (Europe) Taking a biotech innovation from development to proof … If your innovation targets a rare disease, gaining orphan drug designation can expedite its approval process and offer …